Skip to main content
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
16.87
-0.17 (-1.00%)
At close: Feb 21, 2025, 4:00 PM
16.94
+0.07 (0.41%)
After-hours: Feb 21, 2025, 6:35 PM EST

Nurix Therapeutics Revenue

In the fiscal year ending November 30, 2024, Nurix Therapeutics had annual revenue of $54.55M, down -29.15%. Nurix Therapeutics had revenue of $13.28M in the quarter ending November 30, 2024, a decrease of -12.37%.

Revenue (ttm)
$54.55M
Revenue Growth
-29.15%
P/S Ratio
20.76
Revenue / Employee
$190,731
Employees
286
Market Cap
1.28B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202454.55M-22.44M-29.15%
Nov 30, 202376.99M38.36M99.31%
Nov 30, 202238.63M8.88M29.84%
Nov 30, 202129.75M11.93M66.95%
Nov 30, 202017.82M-13.30M-42.73%
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

NRIX News

More News